75A50119C00037

VIGIV BUY AND ASSOCIATED SERVICES

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	ASPR/ORM-SNS
NAICS	325412 — Pharmaceutical Preparation Manufacturing
PSC	6505 — Drugs and Biologicals
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$422.3M
Current contract value	$422.3M
Potential contract value / ceiling	$706.5M
Start date	May 31, 2019
Current end date	Mar 30, 2027
Potential end date	May 30, 2029
Latest award activity	Mar 23, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Mar 23, 2026	P00017	$53.7M	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS.
Jul 2, 2025	P00016	$51.9M	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS.
Jun 30, 2025	P00015	$0	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
Jun 13, 2025	P00014	$0	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
Jun 2, 2025	P00013	$0	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
Mar 4, 2025	P00012	$0	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
Jun 10, 2024	P00011	$62.7M	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
Feb 22, 2024	P00010	$0	VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
May 19, 2023	P00009	$60.6M	EXTENSION OF ORDERING PERIOD FOR OPTION 5/YEAR 5 TO 5/30/2023.
Mar 20, 2023	P00008	$0	EXTENSION OF ORDERING PERIOD FOR OPTION 5/YEAR 5 TO 5/30/2023.
Apr 5, 2022	P00007	$58.5M	OPTION 4 EXERCISE
Mar 29, 2022	P00006	$0	DEADLINE EXTENSION AND INCORPORATION OF IPP CLAUSE
Oct 25, 2021	P00005	$0	EO14042 VIGIV BUY AND ASSOCIATED SERVICES
May 26, 2021	P00004	$56.6M	VIGIV BUY AND ASSOCIATED SERVICES
Mar 26, 2021	P00003	$0	VIGIV BUY AND ASSOCIATED SERVICES
May 21, 2020	P00002	$54.6M	VIGIV BUY AND ASSOCIATED SERVICES
Mar 19, 2020	P00001	$0	VIGIV BUY AND ASSOCIATED SERVICES
May 31, 2019	0	$23.7M	VIGIV BUY AND ASSOCIATED SERVICES

Estimated positioning window

May 30, 2028 – Nov 30, 2028

Recompete signal:

60/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 60/100. Available recorded signals: 55 points.

Contract end 2029-05-30 (941 days from calculation): +15 points
31 historical awards in this buyer and category group: +15 points
18 recorded award transactions: +10 points
Latest award action: 2026-03-23: +5 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Verify whether remaining options may extend performance beyond the current end date.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.